ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The inv...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | GASTAMINZA LANDART, Pablo HERRANZ HERRANZ, Rosario CABRERA TORREJÓN, Daniel BUENO FERNÁNDEZ, Paula GUTIÉRREZ RODRÍGUEZ, Marta CASTRO NAVAS, Francisco F CASTRO ILLANA, Victoria GARAIGORTA DE DIOS, Urtzi |
description | The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I).
La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023217539A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023217539A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023217539A13</originalsourceid><addsrcrecordid>eNrjZNBz9AvxDPMMcvRRcPb3DfAP9XMJVnD0c4Hwgj1DPP39ghVCPFyDXN2C_H15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGxkaG5qbGlo6ExcaoApiQnEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><source>esp@cenet</source><creator>GASTAMINZA LANDART, Pablo ; HERRANZ HERRANZ, Rosario ; CABRERA TORREJÓN, Daniel ; BUENO FERNÁNDEZ, Paula ; GUTIÉRREZ RODRÍGUEZ, Marta ; CASTRO NAVAS, Francisco F ; CASTRO ILLANA, Victoria ; GARAIGORTA DE DIOS, Urtzi</creator><creatorcontrib>GASTAMINZA LANDART, Pablo ; HERRANZ HERRANZ, Rosario ; CABRERA TORREJÓN, Daniel ; BUENO FERNÁNDEZ, Paula ; GUTIÉRREZ RODRÍGUEZ, Marta ; CASTRO NAVAS, Francisco F ; CASTRO ILLANA, Victoria ; GARAIGORTA DE DIOS, Urtzi</creatorcontrib><description>The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I).
La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231116&DB=EPODOC&CC=WO&NR=2023217539A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231116&DB=EPODOC&CC=WO&NR=2023217539A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GASTAMINZA LANDART, Pablo</creatorcontrib><creatorcontrib>HERRANZ HERRANZ, Rosario</creatorcontrib><creatorcontrib>CABRERA TORREJÓN, Daniel</creatorcontrib><creatorcontrib>BUENO FERNÁNDEZ, Paula</creatorcontrib><creatorcontrib>GUTIÉRREZ RODRÍGUEZ, Marta</creatorcontrib><creatorcontrib>CASTRO NAVAS, Francisco F</creatorcontrib><creatorcontrib>CASTRO ILLANA, Victoria</creatorcontrib><creatorcontrib>GARAIGORTA DE DIOS, Urtzi</creatorcontrib><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><description>The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I).
La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz9AvxDPMMcvRRcPb3DfAP9XMJVnD0c4Hwgj1DPP39ghVCPFyDXN2C_H15GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGxkaG5qbGlo6ExcaoApiQnEQ</recordid><startdate>20231116</startdate><enddate>20231116</enddate><creator>GASTAMINZA LANDART, Pablo</creator><creator>HERRANZ HERRANZ, Rosario</creator><creator>CABRERA TORREJÓN, Daniel</creator><creator>BUENO FERNÁNDEZ, Paula</creator><creator>GUTIÉRREZ RODRÍGUEZ, Marta</creator><creator>CASTRO NAVAS, Francisco F</creator><creator>CASTRO ILLANA, Victoria</creator><creator>GARAIGORTA DE DIOS, Urtzi</creator><scope>EVB</scope></search><sort><creationdate>20231116</creationdate><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><author>GASTAMINZA LANDART, Pablo ; HERRANZ HERRANZ, Rosario ; CABRERA TORREJÓN, Daniel ; BUENO FERNÁNDEZ, Paula ; GUTIÉRREZ RODRÍGUEZ, Marta ; CASTRO NAVAS, Francisco F ; CASTRO ILLANA, Victoria ; GARAIGORTA DE DIOS, Urtzi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023217539A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GASTAMINZA LANDART, Pablo</creatorcontrib><creatorcontrib>HERRANZ HERRANZ, Rosario</creatorcontrib><creatorcontrib>CABRERA TORREJÓN, Daniel</creatorcontrib><creatorcontrib>BUENO FERNÁNDEZ, Paula</creatorcontrib><creatorcontrib>GUTIÉRREZ RODRÍGUEZ, Marta</creatorcontrib><creatorcontrib>CASTRO NAVAS, Francisco F</creatorcontrib><creatorcontrib>CASTRO ILLANA, Victoria</creatorcontrib><creatorcontrib>GARAIGORTA DE DIOS, Urtzi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GASTAMINZA LANDART, Pablo</au><au>HERRANZ HERRANZ, Rosario</au><au>CABRERA TORREJÓN, Daniel</au><au>BUENO FERNÁNDEZ, Paula</au><au>GUTIÉRREZ RODRÍGUEZ, Marta</au><au>CASTRO NAVAS, Francisco F</au><au>CASTRO ILLANA, Victoria</au><au>GARAIGORTA DE DIOS, Urtzi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM</title><date>2023-11-16</date><risdate>2023</risdate><abstract>The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. It also relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in medicine, in particular for the prevention of treatment of infection by coronavirus. The invention also relates to a process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof formula (I).
La présente divulgation concerne un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en médecine, en particulier pour la prévention du traitement d'une infection par le coronavirus. L'invention concerne également un procédé de préparation d'un composé de formule (I) ou d'un sel pharmaceutiquement acceptable de celui-ci, formule (I).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2023217539A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | ANTIVIRAL COMPOUNDS AND COMPOSITIONS THEREFROM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T19%3A21%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GASTAMINZA%20LANDART,%20Pablo&rft.date=2023-11-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023217539A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |